-
Chinese vice-premier calls for boosting basic pharmaceutical research, sci-tech innovation
Liu, also a member of the Political Bureau of the Communist Party of China Central Committee, visited Peking University's School of Pharmaceutical Sciences to learn about medical research and development, as well as the construction and operations of key laboratories, and listened to opinions from various relevant parties at a symposium.
-
Li Li meets with head of Uzbekistan’s Center for Safety of Pharmaceutical Products
Li Li, commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Alisher Temirov, acting director of the Center for the Safety of Pharmaceutical Products of the Ministry of Health of Uzbekistan, in Beijing on June 27.
-
NMPA holds meeting to review QMS in vaccine regulation, pharmaceutical manufacturing inspection
The National Medical Products Administration (NMPA) held a meeting on June 9 to conduct the 2024 annual review of the quality management system (QMS) in vaccine regulation and pharmaceutical manufacturing inspection.
- NMPA Announcement on Further Improvement and Optimization of Matters Concerning the Production of Imported Medical Devices in Domestic Enterprises in China (No. 30, 2025)
- NPMA Announcement on Expanding the Implementation Scope of Electronic Common Technical Documents (No.10, 2025)
- Announcement of the National Medical Products Administration and National Health Commission on Issuing the 2025 Edition of the Pharmacopoeia of the People’s Republic of China (No. 29, 2025)
